Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,52 mln. 14,54 mln. | Omzet 2020 | 21,91 mln. 29,92 mln. 20,22 mln. | Marktkapitalisatie | 20,07 mln. 27,41 mln. 18,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -62,82 mln. -42,46 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,66 mln. -9,23 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,5 mln. 5,74 mln. | Nettoschuld 2020 | 10,27 mln. 14,02 mln. 9,48 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,02 mld. | |
-21,28% | 4,19 mld. | |
+4,52% | 3,25 mld. | |
-18,16% | 2,87 mld. | |
-7,70% | 2,37 mld. | |
+41,50% | 1,89 mld. | |
-4,05% | 1,58 mld. | |
-15,56% | 1,54 mld. | |
-14,62% | 1,5 mld. |